Related Experiment Video
Updated: Jul 14, 2026
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Effect of parental smoking on cotinine levels in newborns
D V Joseph1, J A Jackson, J Westaway
1University of Leicester, Leicester Royal Infirmary, Leicester LE2 7LX, UK.
Insights
Infants exposed to parental smoking accumulate significantly higher levels of cotinine, a harmful tobacco metabolite. This passive smoke exposure may negatively impact infant health, particularly the cardiorespiratory system.
Area of Science:
- Environmental Health
- Pediatrics
- Toxicology
Background:
- Parental smoking is a significant risk factor for infant mortality.
- Infants exposed to secondhand smoke accumulate harmful cigarette smoke metabolites.
- Cotinine, a nicotine metabolite, is a biomarker for smoke exposure.
Purpose of the Study:
- To quantify cotinine levels in infants of smoking parents.
- To assess the impact of passive smoke exposure on infant cotinine accumulation.
Main Methods:
- Urine cotinine levels were measured in 104 infants around 12 weeks of age.
- Infants were categorized based on parental smoking status (71 smoking, 33 non-smoking).
- Data was sourced from developmental physiological studies.
Main Results:
- Infants of smoking parents excreted 5.58 times more cotinine than those of non-smoking parents.
- Maternal smoking was the primary contributor to cotinine levels.
- Co-sleeping and lower room temperature were also significant factors.
Conclusions:
- Infants in smoking households accumulate cotinine, a nicotine metabolite.
- This accumulation may adversely affect the infant's cardiorespiratory system.
- Reducing environmental smoke exposure is crucial for infant health.
Background:
Smoking is a major risk factor for cot death. Many infants smoke passively as a result of parental smoking. This paper reports on infants exposed to a smoking environment and how they accumulate metabolites of cigarette smoke, such as cotinine, which may be physiologically harmful.
Aim:
To assess cotinine levels in infants of smoking parents.
Method:
Cotinine excretion in urine was assessed in 104 infants, of whom 71 had smoking parents and 33 had non-smoking parents. All cotinine levels were measured at approximately 12 weeks of age. The subjects were selected from a database of infants in developmental physiological studies which assessed the impact of various factors on early postnatal development.
Results:
On average babies with at least one parent who was a current cigarette smoker excreted 5.58 (95% CI 3.4 to 9.5) times as much cotinine in the urine as did the babies of non-smoking parents. Maternal smoking was the largest contributing factor. Co-sleeping (p = 0.037) and the minimum room temperature (p = 0.028) were significant contributory factors.
Conclusion:
Infants from smoking households accumulate cotinine, a metabolite of nicotine, which may have a detrimental effect on the cardiorespiratory system.
More Related Videos
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...